InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
IMVT
Result 62 decisions over 120 months
Reset filters
Direction ?
Both62 Bought32 Sold30
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: IMVT Plan: Not stated
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
IMVT Immunovant, Inc.
2 Feb 2023
Macias William L.
Chief Medical Officer
Sold, plan not stated
537
$9.79K
0.2%
IMVT Immunovant, Inc.
26 Jan 2023
Levine Mark S.
Chief Legal Officer
Sold, plan not stated
10,156
$187.99K
4.0%
IMVT Immunovant, Inc.
11 Jan 2023
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated 2×
60,490
$1.02M
15.4%
IMVT Immunovant, Inc.
11 Jan 2023
Macias William L.
Chief Medical Officer
Sold, plan not stated 2×
44,568
$746.32K
14.5%
IMVT Immunovant, Inc.
11 Jan 2023
Barnett Eva Renee
Chief Financial Officer
Sold, plan not stated 2×
4,510
$75.52K
1.7%
IMVT Immunovant, Inc.
11 Jan 2023
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
4,021
$67.55K
0.4%
IMVT Immunovant, Inc.
21 Oct 2022
Macias William L.
Chief Medical Officer
Sold, plan not stated
341
$3.30K
0.1%
IMVT Immunovant, Inc.
13 Oct 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
2,793
$25.64K
0.3%
IMVT Immunovant, Inc.
13 Oct 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
928
$8.52K
0.2%
IMVT Immunovant, Inc.
11 Oct 2022
Barnett Eva Renee
Chief Financial Officer
Sold, plan not stated
12,500
$118.00K
4.4%
IMVT Immunovant, Inc.
6 Oct 2022
Roivant Sciences Ltd.
10% owner
Bought
416,667
$2.50M
0.6%
IMVT Immunovant, Inc.
30 Sep 2022
Pande Atul
Director indirect
Bought
15,000
$84.00K
300%
IMVT Immunovant, Inc.
29 Sep 2022
Torti Frank
Director
Bought
20,000
$116.20K
5.4%
IMVT Immunovant, Inc.
28 Sep 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,605
$7.50K
0.2%
IMVT Immunovant, Inc.
28 Sep 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
535
$2.50K
0.1%
IMVT Immunovant, Inc.
30 Aug 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,644
$9.58K
0.2%
IMVT Immunovant, Inc.
30 Aug 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
548
$3.19K
0.1%
IMVT Immunovant, Inc.
27 Jul 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,528
$6.52K
0.3%
IMVT Immunovant, Inc.
27 Jul 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
510
$2.18K
0.2%
IMVT Immunovant, Inc.
22 Jul 2022
Macias William L.
Chief Medical Officer
Sold, plan not stated
322
$1.51K
0.2%
IMVT Immunovant, Inc.
29 Jun 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,376
$5.53K
0.2%
IMVT Immunovant, Inc.
29 Jun 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
460
$1.85K
0.2%
IMVT Immunovant, Inc.
24 May 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,471
$5.58K
0.3%
IMVT Immunovant, Inc.
24 May 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
492
$1.86K
0.2%
IMVT Immunovant, Inc.
27 Apr 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
1,622
$7.66K
0.3%
IMVT Immunovant, Inc.
27 Apr 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
541
$2.55K
0.2%
IMVT Immunovant, Inc.
19 Apr 2022
Macias William L.
Chief Medical Officer
Sold, plan not stated
1,392
$6.93K
0.7%
IMVT Immunovant, Inc.
24 Mar 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
19,227
$113.44K
3.3%
IMVT Immunovant, Inc.
24 Mar 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
6,381
$37.65K
2.2%
IMVT Immunovant, Inc.
7 Jan 2022
Salzmann Peter
Chief Executive Officer
Sold, plan not stated
125,158
$907.40K
17.8%
IMVT Immunovant, Inc.
7 Jan 2022
Butchko Julia G.
Chief Dev. & Tech. Officer
Sold, plan not stated
55,318
$401.06K
16.0%
IMVT Immunovant, Inc.
7 Jan 2022
Barnett Eva Renee
Chief Financial Officer
Sold, plan not stated
29,959
$217.20K
14.8%
IMVT Immunovant, Inc.
5 Jan 2022
Macias William L.
Chief Medical Officer
Sold, plan not stated
26,813
$222.01K
12.0%
IMVT Immunovant, Inc.
27 Aug 2021
Hughes Douglas J.
Director
Bought
18,247
$150.36K
45.4%
IMVT Immunovant, Inc.
20 Aug 2021
MIGAUSKY GEORGE V
Director
Bought
7,000
$53.55K
11.6%
IMVT Immunovant, Inc.
13 Aug 2021
Pande Atul
Director indirect
Bought
5,000
$39.90K
12.4%
IMVT Immunovant, Inc.
10 Aug 2021
Fromkin Andrew J.
Director
Bought
5,500
$43.45K
13.7%
IMVT Immunovant, Inc.
11 Sep 2020
Butchko Julia G.
Chief Dev. & Tech. Officer
Bought
5,000
$190.85K
opened
IMVT Immunovant, Inc.
4 Sep 2020
Roivant Sciences Ltd.
10% owner
Bought
380,000
$12.54M
0.8%
IMVT Immunovant, Inc.
16 Apr 2020
Roivant Sciences Ltd.
10% owner
Bought
1,034,483
$15.00M
2.8%
IMVT Immunovant, Inc.
11 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
31,500
$344.02K
3.6%
IMVT Immunovant, Inc.
10 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
25,971
$269.52K
3.1%
IMVT Immunovant, Inc.
6 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought 2×
450,000
$4.61M
114%
IMVT Immunovant, Inc.
5 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
20,000
$203.00K
5.3%
IMVT Immunovant, Inc.
4 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
20,000
$203.00K
5.6%
IMVT Immunovant, Inc.
3 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
20,000
$204.20K
6.0%
IMVT Immunovant, Inc.
2 Dec 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
20,000
$208.00K
6.3%
IMVT Immunovant, Inc.
29 Nov 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
26,918
$281.29K
9.3%
IMVT Immunovant, Inc.
27 Nov 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
4,000
$41.90K
1.4%
IMVT Immunovant, Inc.
26 Nov 2019
WONG RODERICK
Chief Executive Officer indirect
Bought
4,000
$41.96K
1.4%
Showing 1–50 of 62. Page 1 of 2 Older →